Replimune Group Inc sell BMO Capital Markets
Start price
23.07.25
/
50%
€2.40
Target price
23.07.26
€1.70
Performance (%)
62.50%
Price
10.10.25
€3.90
Summary
This prediction is currently active. The SELL prediction by BMO_Capital_Markets for Replimune Group Inc is trending in the completely wrong direction and now has a performance of 62.50%. This prediction currently runs until 23.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Replimune Group Inc | 0.000% | 0.000% |
| iShares Core DAX® | -0.693% | 2.676% |
| iShares Nasdaq 100 | -1.173% | 2.362% |
| iShares Nikkei 225® | -1.388% | 3.465% |
| iShares S&P 500 | -1.411% | 1.137% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-69.77%
10.10.25
10.10.25
Replimune Group Inc
Start price
Target price
Perf. (%)
€15.40
22.11.24
22.11.24
€17.31
22.11.25
22.11.25
-74.68%
10.10.25
10.10.25